Emerald Health Therapeutics (CVE:EMH) Stock Price Down 4.1%
Shares of Emerald Health Therapeutics Inc (CVE:EMH) were down 4.1% during trading on Tuesday . The company traded as low as C$1.63 and last traded at C$1.65, approximately 265,518 shares changed hands during mid-day trading. A decline of 59% from the average daily volume of 646,024 shares. The stock had previously closed at C$1.72.
The stock has a 50-day simple moving average of C$1.96 and a 200 day simple moving average of C$3.03. The company has a debt-to-equity ratio of 4.79, a quick ratio of 0.42 and a current ratio of 0.92. The company has a market cap of $242.10 million and a P/E ratio of -10.25.
In other Emerald Health Therapeutics news, Director Sukhwinder Singh Rai sold 180,000 shares of the firm’s stock in a transaction that occurred on Friday, July 19th. The stock was sold at an average price of C$0.34, for a total value of C$60,300.00. Following the completion of the sale, the director now owns 345,000 shares in the company, valued at approximately C$115,575.
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis in Canada. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Victoria, Canada.
Featured Article: Dead Cat Bounce
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.